IP Library Granted Patent US 9,731,136
Granted Patent B2
US 9,731,136 · App. 15/163,078 · Granted Aug 15, 2017

Methods and apparatus to stimulate the heart

Inventors: Howard Levin (Teaneck, NJ); Mark Gelfand (New York, NY)
Assignee: BackBeat Medical, Inc.
A61N1/36542A61N1/368A61N1/3621A61N1/3627A61N1/3684A61N1/36117A61N1/36564
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,731,136
App. No.
15/163,078
Granted
Aug 15, 2017
Kind
B2
Abstract

A method and apparatus for treatment of hypertension and heart failure by increasing secretion of endogenous atrial hormones by pacing of the heart. Pacing is done during the ventricular refractory period resulting in premature atrial contraction that does not result in ventricular contraction. Pacing results in the atrial wall stress, peripheral vasodilation, ANP secretion. Concomitant reduction of the heart rate is monitored and controlled as needed with backup pacing.

Claims (32)

1. A method for controlling heart contraction to reduce blood pressure, the method comprising:

allowing for a first atrial contraction of an atrium of a heart of a patient;

allowing for a first ventricular contraction of a ventricle of the heart of the patient;

pacing the heart during a pacing period after expiration of an atrial refractory period associated with the first atrial contraction and within a ventricular refractory period associated with the first ventricular contraction; and

causing, by the pacing of the heart during the pacing period, a second atrial contraction without eliciting a corresponding second ventricular contraction.

2. The method of claim 1 , wherein allowing for the first atrial contraction comprises one of sensing the first atrial contraction and pacing the first atrial contraction, and

wherein allowing for the first ventricular contraction comprises one of sensing the first ventricular contraction and pacing the first ventricular contraction.

3. The method of claim 1 , wherein the second atrial contraction causes a vasodilation and a release of natriuretic hormone.

4. The method of claim 1 , wherein the second atrial contraction occurs when the atrium is distended with blood.

5. A method for treating a blood pressure disorder in a patient, the method comprising:

pacing a heart of the patient so as to cause an atrial contraction against a closed heart valve;

causing increased atrial wall stress by the atrial contraction;

causing release of a natriuretic hormone by the increased atrial wall stress; and

reducing the patient's blood pressure from a pretreatment blood pressure by the released natriuretic hormone.

6. A device for controlling heart rate by pacing a heart of a patient having an atrium and a ventricle, the device comprising:

at least one electrically conductive lead configured to connect to the heart of the patient;

an electrical pulse generator connectable to the at least one electrically conductive lead and configured to:

pace, after a first ventricular contraction of the heart, the atrium of the heart, wherein the atrial pace occurs after expiration of an atrial refractory period of the heart and during a ventricular refractory period of the heart, and

cause an atrial contraction as a result of the atrial pace,

wherein the atrial contraction does not elicit a second ventricular contraction.

7. The device of claim 6 , wherein the electrical pulse generator is configured to cause the atrial contraction when the atrium is distended with blood.

8. The device of claim 6 , wherein the atrial contraction causes a vasodilation and a release of a natriuretic hormone in the heart.

9. The device of claim 8 , wherein the electrical pulse generator is configured to monitor a ventricular contraction rate resulting from the atrial pace to determine whether the atrial pace conducts to the ventricle, and to adjust the atrial pace based on the monitoring.

10. The device of claim 8 , wherein the electrical pulse generator is configured to pace the atrium upon expiration of a predetermined delay after the first ventricular contraction.

11. The device of claim 10 , wherein the electrical pulse generator is configured to adjust the predetermined delay based on a detected propagation of the atrial pace to the ventricle.

12. The device of claim 10 , wherein the predetermined delay is between approximately 150 milliseconds and 300 milliseconds after the first ventricular contraction.

13. The device of claim 8 , wherein the electrical pulse generator is configured to monitor a spontaneous heart beat after the electrical pulse generator applies an atrial pacing pulse, and to deliver another atrial pacing pulse if a predetermined delay after the first ventricular contraction is longer than a predetermined period corresponding to a lowest selected heart rate, wherein the another atrial pacing pulse generates ventricular contraction.

14. The device of claim 13 , wherein the lowest selected heart rate is less than approximately 50 beats per minute.

15. The device of claim 8 , wherein the electrical pulse generator is configured to cause the atrial contraction in approximately a middle of ventricular systole.

16. The device of claim 8 , wherein the electrical pulse generator is configured to cause the atrial contraction when an atrioventricular valve between the atrium and the ventricle is closed.

17. The device of claim 8 , wherein the electrical pulse generator is configured to pace a right atrium, a left atrium, or both the left and right atria.

18. The device of claim 8 , wherein during a given cardiac cycle a first atrial contraction occurs followed by the first ventricular contraction, and wherein, in being configured to cause the atrial contraction as a result of the atrial pace, the electrical pulse generator is configured to cause a second atrial contraction after the first atrial contraction and the first ventricular contraction.

Assignments (8)
SECURITY INTEREST Recorded Aug 7, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: MEDTRONIC, INC.
Reel/Frame 072341/0075 →
SECURITY INTEREST Recorded Aug 4, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: LIGAND PHARMACEUTICALS, INC.
Reel/Frame 072359/0219 →
SECURITY INTEREST Recorded Nov 6, 2024
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC
To: HERCULES CAPITAL, INC.
Reel/Frame 069312/0758 →
RELEASE OF IP SECURITY INTEREST Recorded Oct 9, 2023
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
Reel/Frame 065192/0001 →
SECURITY AGREEMENT Recorded Jun 6, 2022
From: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 060286/0021 →
ENTITY CONVERSION Recorded Feb 13, 2020
From: BACKBEAT MEDICAL, INC.
To: BACKBEAT MEDICAL, LLC
Reel/Frame 051930/0075 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2016
From: LEVIN, HOWARD; GELFAND, MARK
To: G & L CONSULTING, LLC
Reel/Frame 038707/0101 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2016
From: G & L CONSULTING, LLC
To: BACKBEAT MEDICAL, INC.
Reel/Frame 038707/0294 →
Continuity (4)
Continuation 13688978 · Nov 29, 2012
Continuation 12555389 · Sep 8, 2009
Provisional Application 61095120 · Sep 8, 2008
Related Publication 20160263383A1 · Sep 15, 2016